English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90429/105609 (86%)
Visitors : 10277217      Online Users : 320
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/111355


    Title: The Contribution of Matrix Metalloproteinase-1 Promoter Genotypes in Taiwan Lung Cancer Risk
    Authors: Shen, Te-Chun;Shen, Te-Chun;Cha, Wen-Shin;Chang, Wen-Shin;Tsa, Chia-Wen;Tsai, Chia-Wen;趙哲毅;Chao, Che-Yi;Lin, Yi-Ting;Lin, Yi-Ting;Hs, Chieh-Lun;Hsiao, Chieh-Lun;Hsu, Che-Lun;Hsu, Che-Lun;Che, Wei-Chun;Chen, Wei-Chun;Hsia, Te-Chun;Hsia, Te-Chun;包大?;Bau, Da-Tian;*
    Contributors: 生物資訊與醫學工程學系
    Date: 2018-01
    Issue Date: 2018-08-20 09:45:08 (UTC+8)
    Abstract: BACKGROUND/AIM:
    Up-regulation of metallo-proteinase (MMP) proteins has been shown in various types of solid cancers and the genotype of MMP1 has been associated with the risk of solid cancers. The contribution of MMP1 genotype to lung cancer has been investigated in various countries, though, to our knowledge, not in Taiwan. Therefore, in this study, we focused on the contribution of a polymorphism in the promoter region of MMP1 to lung cancer risk in Taiwan population.

    PATIENTS AND METHODS:
    Genomic DNA was isolated from peripheral blood of 358 patients with lung cancer and 716 healthy individuals (non-cancer patients). MMP1 rs1799750 polymorphic genotypes of each sample were determined using the typical methodology of polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).

    RESULTS:
    The percentages of 2G/2G, 1G/2G, and 1G/1G for MMP1 -1607 genotypes were 34.4%, 41.3% and 24.3% in the disease group and 33.9%, 44.0%, and 22.1% in the control group (p trend=0.6298), respectively. The results of carrier comparisons in dominant and recessive models also support the findings that 1G or 2G appears not to be a determinant allelic biomarker for Taiwan lung cancer.

    CONCLUSION:
    The MMP1 -1607 1G allele is a non-significant protective biomarker for lung cancer in Taiwan.

    Copyright© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

    KEYWORDS:
    Genotype; MMP1; Taiwan; lung cancer; non-synonymous; polymorphism
    Relation: ANTICANCER RESEARCH
    Appears in Collections:[生物資訊與醫學工程學系 ] 期刊論文

    Files in This Item:

    There are no files associated with this item.



    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback